GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED financial statements, including revenue, expenses, profit, and loss
The total revenue of 600332 for the last quarter is 22.85 B CNY, and it's 32.55% higher compared to the previous quarter. The net income of Q1 24 is 1.96 B CNY.